Drug screening and treatment for hiv thymocyte depletion

Details Drug screening and treatment for hiv thymocyte depletion Drug screening and treatment for hiv thymocyte depletion

C - Chemistry, Metallurgy

12

Q

C12Q 1/02 (2006.01) A01K 67/027 (2006.01) A61K 38/13 (2006.01) A61K 49/00 (2006.01) G01N 33/48 (2006.01)

Patent

CA 2131700

2131700 9323084 PCTABS00028 Method is provided for screening compounds for the ability to suppress thymocyte depletion in thymuses of HIV-infected individuals, particularly enhancing the CD4+-expressing population as compared to an untreated individual. Particularly, drugs are provided which allow for this result, cyclosporine A being exemplary.

Affiliated with

Also associated with

Rating

Drug screening and treatment for hiv thymocyte depletion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug screening and treatment for hiv thymocyte depletion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug screening and treatment for hiv thymocyte depletion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1967209